BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21643632)

  • 1. Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases.
    Carrafiello G; Fontana F; Cotta E; Petullà M; Brunese L; Mangini M; Fugazzola C
    Radiol Med; 2011 Oct; 116(7):1059-66. PubMed ID: 21643632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
    Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
    Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
    White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
    Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.
    Veltri A; Guarnieri T; Gazzera C; Busso M; Solitro F; Fora G; Racca P
    Radiol Med; 2012 Oct; 117(7):1139-51. PubMed ID: 22430677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma.
    Pan C; Wu P; Yu J; Li W; Huang Z; He N; Wang J; Zhao M
    Int J Hyperthermia; 2011; 27(6):549-54. PubMed ID: 21846191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic radiofrequency under CT-fluoroscopy guidance.
    Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
    Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation for treating liver metastases from a non-colorectal origin.
    Yun BL; Lee JM; Baek JH; Kim SH; Lee JY; Han JK; Choi BI
    Korean J Radiol; 2011; 12(5):579-87. PubMed ID: 21927559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept.
    Ritz JP; Lehmann KS; Reissfelder C; Albrecht T; Frericks B; Zurbuchen U; Buhr HJ
    Int J Colorectal Dis; 2006 Jan; 21(1):25-32. PubMed ID: 15875202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-guided radiofrequency ablation (RFA) for inoperable gastrointestinal liver metastases.
    Hofer S; Oberholzer C; Beck S; Looser C; Ludwig C
    Ultraschall Med; 2008 Aug; 29(4):388-92. PubMed ID: 18785319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.
    Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT
    Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease.
    Veltri A; Gazzera C; Barrera M; Busso M; Solitro F; Filippini C; Garetto I
    Radiol Med; 2014 May; 119(5):327-33. PubMed ID: 24297589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
    Mahnken AH; Bruners P; Tacke JA; Günther RW
    Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases.
    Minami Y; Minami T; Chishina H; Kono M; Arizumi T; Takita M; Yada N; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
    Dig Dis; 2016; 34(6):687-691. PubMed ID: 27750238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
    Lorentzen T; Skjoldbye BO; Nolsoe CP
    Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Metastasis From Ovarian Cancer: A Single-Center Initial Experience.
    Liu B; Huang G; Jiang C; Xu M; Zhuang B; Lin M; Tian W; Xie X; Kuang M; Xie X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1261-1267. PubMed ID: 28640176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.